Dr. Lal Path Labs Ltd. — Financials & Forensics

Sector: Healthcare · NSE: LALPATHLAB · BSE: 539524 · ISIN: INE600L01024

₹1,900.15

Closing price
18 Aug 2026

-44.6%

1-year price change

₹31,847 Cr

Market cap

62.5×

P/E ratio (trailing)

21.5%

Return on Equity (FY)

0.70%

Dividend yield

⚡ What you get within minutes of every filing

ISA

Indian Stock Alerts BOT

🚨 LALPATHLAB — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add LALPATHLAB to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

Loading chart…

Annual P&L snapshot

Line item	FY22	FY23	FY24	FY25	FY26
Revenue from operations	₹2,087 Cr	₹2,017 Cr	₹2,227 Cr	₹2,461 Cr	₹2,763 Cr
EBITDA	₹561 Cr	₹490 Cr	₹609 Cr	₹696 Cr	₹782 Cr
EBITDA margin	26.9%	24.3%	27.4%	28.3%	28.3%
Profit after tax	₹350 Cr	₹241 Cr	₹362 Cr	₹492 Cr	₹510 Cr

Source: Dr. Lal Path Labs Ltd.'s regulatory filings under SEBI LODR Regulation 33. View full financials →

Deeper analysis

Recent filings by Dr. Lal Path Labs Ltd.

Intimation - Tenure Completion of an Independent Director
26 Jul 2026 · Management Change
Attached
25 Jul 2026 · Corporate Action
Proceeding of the 32nd AGM is attached
25 Jul 2026 · General Update
Attached
25 Jul 2026 · Regulatory Compliance
Attached
24 Jul 2026 · General Update

Never miss a filing again

Add stocks to watchlist

Get instant Telegram alerts

Get started — it's free →

14-day Pro trial included · No credit card required

About Dr. Lal Path Labs Ltd. on Indian Stock Alerts

Indian Stock Alerts tracks Dr. Lal Path Labs Ltd.'s SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.

Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.

Important. All data on this page is sourced from Dr. Lal Path Labs Ltd.'s own public regulatory filings under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Investors should consult registered advisers before making investment decisions.